Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000512918 | SCV000608810 | uncertain significance | not provided | 2017-04-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000512918 | SCV000702360 | uncertain significance | not provided | 2016-11-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316454 | SCV000850874 | likely benign | Inborn genetic diseases | 2017-04-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000512918 | SCV001829612 | likely benign | not provided | 2020-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000512918 | SCV002409153 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925515 | SCV004742070 | likely benign | RAI1-related disorder | 2019-09-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |